Prelude Capital Management, LLC Insmed Inc Transaction History

Prelude Capital Management, LLC

$1.57 Billion
Q3 2024

A detailed history of Prelude Capital Management, LLC transactions in Insmed Inc stock. As of the latest transaction made, Prelude Capital Management, LLC holds 11,049 shares of INSM stock, worth $732,438. This represents 0.05% of its overall portfolio holdings.

Number of Shares

11,049

Previous 11,049 -0.0%

Holding current value

$732,438

Previous $806,000 -0.0%

% of portfolio

0.05%

Previous 0.03%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$62.0 - $79.01 $102,362 - $130,445	-1,651 Reduced 13.0%	11,049 $806,000
Q2 2024 Aug 14, 2024	SELL	$22.0 - $69.71 $101,288 - $320,944	-4,604 Reduced 26.61%	12,700 $850,000
Q1 2024 May 15, 2024	BUY	$25.72 - $29.94 $100,410 - $116,885	3,904 Added 29.13%	17,304 $469,000
Q3 2023 Nov 14, 2023	BUY	$19.86 - $26.93 $266,124 - $360,862	13,400 New	13,400 $338,000
Q4 2019 Feb 14, 2020	SELL	$16.12 - $24.98 $6,786 - $10,516	-421 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$15.49 - $25.78 $640,248 - $1.07 Million	-41,333 Reduced 98.99%	421 $7,000
Q2 2019 Aug 14, 2019	BUY	$23.0 - $32.19 $584,729 - $818,366	25,423 Added 155.67%	41,754 $1.07 Million
Q1 2019 May 15, 2019	BUY	$13.91 - $31.15 $225,230 - $504,380	16,192 Added 11648.92%	16,331 $475,000
Q4 2018 Feb 14, 2019	SELL	$11.6 - $18.7 $2.03 Million - $3.27 Million	-174,727 Reduced 99.92%	139 $2,000
Q3 2018 Nov 14, 2018	BUY	$18.95 - $28.08 $1.35 Million - $2.01 Million	71,481 Added 69.14%	174,866 $3.54 Million
Q2 2018 Aug 14, 2018	BUY	$20.0 - $29.72 $320,940 - $476,916	16,047 Added 18.37%	103,385 $2.45 Million
Q1 2018 May 15, 2018	BUY	$21.69 - $32.99 $76,609 - $116,520	3,532 Added 4.21%	87,338 $1.97 Million
Q4 2017 Feb 14, 2018	SELL	$26.43 - $31.78 $660,591 - $794,309	-24,994 Reduced 22.97%	83,806 $2.61 Million
Q3 2017 Nov 14, 2017	BUY	$11.61 - $31.21 $1.26 Million - $3.4 Million	108,800	108,800 $3.4 Million

Others Institutions Holding INSM

# of Institutions

465

Shares Held

182M

Call Options Held

2.27M

Put Options Held

3.33M

View Full List

About INSMED Inc

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $8.98B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

More about INSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Account

Prelude Capital Management, LLC Insmed Inc Transaction History